iifl-logo

Bliss GVS Pharma Ltd Share Price Live

Add as a Preferred Source on Google
₹655.95
(-1.76%)
Oct 9, 2026|03:58:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹667.1
  • Day's High₹667.1
  • 52 Wk High₹739.9
  • Prev. Close₹667.7
  • Day's Low₹634.35
  • 52 Wk Low ₹118
  • Turnover (lac)1,038.02
  • P/E61.59
  • Face Value₹1
  • Book Value₹112.28
  • EPS10.9
  • Mkt. Cap (Cr.)₹6,974.75
  • Div. Yield0.15
View All Historical Data

No Record Found

No Record Found

Bliss GVS Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹667.1

Prev. Close

₹667.7

Turnover(Lac.)

₹1,038.02

Day's High

₹667.1

Day's Low

₹634.35

52 Week's High

₹739.9

52 Week's Low

₹118

Book Value

₹112.28

Face Value

₹1

Mkt Cap (₹ Cr.)

6,974.75

P/E

61.59

EPS

10.9

Divi. Yield

0.15

Bliss GVS Pharma Ltd Corporate Action

12 May 2026

12:00 AM

AGM

Announcement Date: 12 May, 2026

arrow

23 Jun 2026

12:00 AM

BookCloser

arrow

28 Sep 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

12 May 2026

12:00 AM

Dividend

Dividend Amount: 1

Record Date: 08 Jul, 2026

arrow

Bliss GVS Pharma Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Bliss GVS Pharma Ltd SHAREHOLDING SNAPSHOT

10 Oct, 2026|10:38 AM
Jun-2026Mar-2026Dec-2025Sep-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 35.00%

Foreign: 0.00%

Indian: 35.00%

Non-Promoter- 17.53%

Institutions: 17.53%

Non-Institutions: 47.45%

Custodian: 0.00%

Read More
Share PriceShare Price

Bliss GVS Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

10.58

10.54

10.51

10.42

Preference Capital

0

0

0

0

Reserves

1,144.61

1,048.1

977.94

926.58

Net Worth

1,155.19

1,058.64

988.45

937

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Revenue

636.35

465.51

441.95

426.59

yoy growth (%)

36.7

5.33

3.6

43.2

Raw materials

-343.94

-253.3

-236.72

-225.14

As % of sales

54.04

54.41

53.56

52.77

Employee costs

-65.05

-58.6

-44.02

-33.84

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

123.65

91.18

121.71

120.01

Depreciation

-13.84

-13.76

-8.83

-5.74

Tax paid

-33.73

-23.68

-29.37

-45.57

Working capital

74.06

16.34

44.64

-0.64

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2019

Growth matrix (%)

Revenue growth

36.7

5.33

3.6

43.2

Op profit growth

19.39

-8.69

7.58

5.23

EBIT growth

34.17

-24.46

2.52

31.32

Net profit growth

37.27

-26.89

24.04

30.55

View Ratios
Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

927.11

809.73

770.24

751.59

747.45

Excise Duty

0

0

0

0

0

Net Sales

927.11

809.73

770.24

751.59

747.45

Other Operating Income

0

0

0

0

0

Other Income

73.53

36.49

28.74

17.79

31.49

Bliss GVS Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,760

132.064,20,483.451,115.140.915,641.3193.23

Divis Laboratories Ltd

DIVISLAB

9,340

83.22,49,248.458910.322,974629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,656.9

86.71,77,821.974920.724,073222.76

Zydus Lifesciences Ltd

ZYDUSLIFE

1,117.5

30.521,11,241.63339.60.092,723.5237.3

Laurus Labs Ltd

LAURUSLABS

2,036.6

123.841,08,062.44289.960.11,757.1697.2

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Bliss GVS Pharma Ltd

Management

Register Office

Registrar Office

Chairman & Independent Directo

Nandkumar Kashinath Chodankar

Independent Non Executive Women Director

Shilpa Bhatia

Independent Non Exe. Director

Vijayanarayanan Mahadevan

Independent Non Exe. Director

Deepak Rameshchandra Shah

Company Secretary

Aditi Bhatt

Additional Director

Hetul Krishnakant Mehta

Additional Director

Amar Dilip Shah

Additional Director

Pramod Kasat

Registered Office

102 Hyde Park Sakivihar Road,

Andheri East,

Maharashtra - 400072

Tel: 91-22-42160000

Website: http://www.blissgvs.com

Email: cs@blissgvs.com; info@blissgvs.com

Registrar Office

21 Shakil Niwas,

Mahakali Caves Road, Andheri (E),

Mumbai - 400 093

Tel: 91-22-28262920

Website: www.unisec.in

Email: info@unisec.in

Summary

Bliss GVS Pharma Limited was originally incorporated as a Private limited company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Lim...
Read More

Reports by Bliss GVS Pharma Ltd

Company FAQs

The Bliss GVS Pharma Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹655.95 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bliss GVS Pharma Ltd is ₹6974.75 Cr. as of 09 Oct ‘26
The PE and PB ratios of Bliss GVS Pharma Ltd is 61.59 and 6.18 as of 09 Oct ‘26
The 52-week high/low is the highest and lowest price at which a Bliss GVS Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bliss GVS Pharma Ltd is ₹118 and ₹739.9 as of 09 Oct ‘26
Bliss GVS Pharma Ltd's CAGR for 5 Years at 42.67%, 3 Years at 96.02%, 1 Year at 339.22%, 6 Month at 164.43%, 3 Month at 30.17% and 1 Month at -7.56%.
The shareholding pattern of Bliss GVS Pharma Ltd is as follows:
Promoters - 35.01 %
Institutions - 17.54 %
Public - 47.45 %

QUICKLINKS FOR Bliss GVS Pharma Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.